$272.73
1.730.64%
At Close: -
$272.73
00.00%
After Hours: 4:52 PM EDT
15 minutes delayed
Alnylam Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Alnylam Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-01 | $0.56 | $-1.08 | 151.8 % |
Mar 2024 | 2024-05-02 | $-0.16 | $-1.18 | 86.4 % |
Dec 2023 | 2024-02-15 | $-0.77 | $-1.33 | 42.1 % |
Sep 2023 | 2023-11-02 | $1.74 | $-1.36 | 227.9 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-01 | $659.83M | $444.11M | 48.6 % |
Mar 2024 | 2024-05-02 | $494.33M | $427.33M | 15.7 % |
Dec 2023 | 2024-02-15 | $439.72M | $442.90M | -0.72 % |
Sep 2023 | 2023-11-02 | $750.53M | $401.03M | 87.2 % |
Alnylam Pharmaceuticals (ALNY) is scheduled to report earnings on October 31, 2024. The last reported earnings were for reported on August 1, 2024 for Q2.
The Actual EPS was $0.56, which beat the estimate of $-1.08.
The Actual Revenue was $659.8M, which beat the estimate of $444.1M.
Browse earnings estimates, EPS, and revenue on all stocks.